Literature DB >> 16362626

Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome.

M Shamoto-Nagai1, W Maruyama, H Yi, Y Akao, F Tribl, M Gerlach, T Osawa, P Riederer, M Naoi.   

Abstract

Parkinson's disease is characterized by the selective depletion of dopamine neurons in the substantia nigra, particular those containing neuromelanin. Involvement of neuromelanin in the pathogenesis may be either cytotoxic or protective. Recently we found that neuromelanin reduces the activity of 26S proteasome. In this paper, the detailed mechanisms behind the reduced activity were studied using neuromelanin isolated from the human brain. Neuromelanin increased the oxidative stress, but synthetic melanin did not. Superoxide dismutase and deferoxamine completely suppressed the increase, indicating that superoxide produced by an iron-mediated reaction plays a central role. Iron was shown to reduce in situ 26S proteasome activity in SH-SY5Y cells and the reduction was protected by antioxidants. These results suggest that iron released from neuromelanin increases oxidative stress in mitochondria, and then causes mitochondrial dysfunction and reduces proteasome function. The role of neuromelanin is discussed in relation to the selective vulnerability of dopamine neurons in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362626     DOI: 10.1007/s00702-005-0410-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.850


  42 in total

1.  The ubiquitin pathway in Parkinson's disease.

Authors:  E Leroy; R Boyer; G Auburger; B Leube; G Ulm; E Mezey; G Harta; M J Brownstein; S Jonnalagada; T Chernova; A Dehejia; C Lavedan; T Gasser; P J Steinbach; K D Wilkinson; M H Polymeropoulos
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

2.  Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly.

Authors:  K Ii; H Ito; K Tanaka; A Hirano
Journal:  J Neuropathol Exp Neurol       Date:  1997-02       Impact factor: 3.685

Review 3.  Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.

Authors:  Kevin St P McNaught; C Warren Olanow
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

4.  In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.

Authors:  W P Gai; H X Yuan; X Q Li; J T Power; P C Blumbergs; P H Jensen
Journal:  Exp Neurol       Date:  2000-12       Impact factor: 5.330

5.  Proteasome inhibition causes nigral degeneration with inclusion bodies in rats.

Authors:  Kevin St P McNaught; Lars M Björklund; Roger Belizaire; Ole Isacson; Peter Jenner; C Warren Olanow
Journal:  Neuroreport       Date:  2002-08-07       Impact factor: 1.837

6.  An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells.

Authors:  Masayo Shamoto-Nagai; Wakako Maruyama; Yoji Kato; Ken-ichi Isobe; Masashi Tanaka; Makoto Naoi; Toshihiko Osawa
Journal:  J Neurosci Res       Date:  2003-11-15       Impact factor: 4.164

7.  Binding of 1,2(N)-dimethyl-6,7-dihydroxy-isoquinolinium ion to melanin: effects of ferrous and ferric ion on the binding.

Authors:  M Naoi; W Maruyama; P Dostert
Journal:  Neurosci Lett       Date:  1994-04-25       Impact factor: 3.046

8.  Neuromelanin of the human substantia nigra: a mixed-type melanin.

Authors:  G Odh; R Carstam; J Paulson; A Wittbjer; E Rosengren; H Rorsman
Journal:  J Neurochem       Date:  1994-05       Impact factor: 5.372

9.  Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis.

Authors:  S Desagher; A Osen-Sand; A Nichols; R Eskes; S Montessuit; S Lauper; K Maundrell; B Antonsson; J C Martinou
Journal:  J Cell Biol       Date:  1999-03-08       Impact factor: 10.539

10.  Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

Authors:  D Sulzer; J Bogulavsky; K E Larsen; G Behr; E Karatekin; M H Kleinman; N Turro; D Krantz; R H Edwards; L A Greene; L Zecca
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

View more
  25 in total

Review 1.  Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle.

Authors:  F Tribl; K Marcus; H E Meyer; G Bringmann; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-05-05       Impact factor: 3.575

2.  Single-Cell Approaches for Studying the Role of Mitochondrial DNA in Neurodegenerative Disease.

Authors:  Laura J Bailey; Joanna L Elson; Ilse S Pienaar
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

4.  Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types.

Authors:  J A Lockman; W J Geldenhuys; K A Bohn; S F Desilva; D D Allen; C J Van der Schyf
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

5.  Dopamine D₂/D₃ agonists with potent iron chelation, antioxidant and neuroprotective properties: potential implication in symptomatic and neuroprotective treatment of Parkinson's disease.

Authors:  Sanjib Gogoi; Tamara Antonio; Subramanian Rajagopalan; Maarten Reith; Julie Andersen; Aloke K Dutta
Journal:  ChemMedChem       Date:  2011-05-12       Impact factor: 3.466

6.  Brain Ceruloplasmin Expression After Experimental Intracerebral Hemorrhage and Protection Against Iron-Induced Brain Injury.

Authors:  Hongwei Liu; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Transl Stroke Res       Date:  2018-10-12       Impact factor: 6.829

7.  Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's disease.

Authors:  Balaram Ghosh; Tamara Antonio; Maarten E A Reith; Aloke K Dutta
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

Review 8.  Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells.

Authors:  Julie A Gaasch; Paul R Lockman; Werner J Geldenhuys; David D Allen; Cornelis J Van der Schyf
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 3.996

9.  Neuromelanin Modulates Heterocyclic Aromatic Amine-Induced Dopaminergic Neurotoxicity.

Authors:  Vivek Lawana; Se Young Um; Jean-Christophe Rochet; Robert J Turesky; Jonathan H Shannahan; Jason R Cannon
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

Review 10.  Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival.

Authors:  Makoto Naoi; Wakako Maruyama; Hong Yi; Keiko Inaba; Yukihiro Akao; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.